EP1165794A1 - Pathogen inducible promoter - Google Patents

Abstract

This invention describes a pathogen-inducible promoter isolated from Arabidopsis thaliana. Also claimed are chimeric constructs where this pathogen-inducible promoter drives expression of antipathogenic proteins or of proteins which can elicit a hypersensitive response.

Description

PATHOGEN INDUCIBLE PROMOTER Field of the Invention

This invention relates to the field of pathogen inducible promoters and chimeric DNA sequences comprising said promoters, especially in the area of plant biotechnology.

Background Art

Inducible promoters include any promoter capable of increasing the amount of gene product produced by a given gene, in response to exposure to an inducer. In the absence of an inducer the DNA sequence will not be transcribed. Typically, the factor that binds specifically to an inducible promoter to activate transcription is present in an inactive form which is then directly or indirectly converted to the active form by the inducer. The inducer may be a chemical agent such as a protein, metabolite (sugar, alcohol, etc.), a growth regulator, herbicide, or a phenolic compound or a physiological stress imposed directly by heat, salt, wounding, toxic elements etc., or indirectly through the action of a pathogen or disease agent such as a virus. A plant cell containing an inducible promoter may be exposed to an inducer by externally applying the inducer to the cell such as by spraying, watering, heating, or similar methods. Inducible promoters are known to those familiar with the art and several exist that could conceivably be used to drive expression of the genes of the invention. Examples of inducible promoters include the inducible 70 kD heat shock promoter of Drosophila melanogaster (Freeling. M. et al., Ann. Rev. Genet. 19, 297-323) and the alcohol dehydrogenase promoter which is induced by ethanol (Nagao, R.T. et al, in: Miflin, B.J. (ed.) Oxford Surveys of Plant Molecular and Cell Biology, Vol. 3., pp. 384-438. Oxford Univ. Press, 1986). Examples for promoters that are inducible by a simple chemical are the promoters described in WO 90/08826, WO 93/21334. WO 93/031294 and WO 96/37609.

An important subclass of inducible promoters are the promoters which are induced in plants upon pathogen infection. As examples of a pathogen-inducible promoter the PRP1 promoter (also named gstl promoter) obtainable from potato (Martini N. et al. (1993), Mol. Gen. Genet. 263, 179-186), the Fisl promoter (WO 96/34949), the Bet v 1 promoter (Swoboda. I., et al.. Plant, Cell and En v. 18. 865-874, 1995), the Vstl promoter (Fischer, R.. Dissertation. Univ. of Hohenheim, 1994; Schubert, R., et al. Plant Mol. Biol. 34, 417-426. 1997). the sesquiterpene cyclase promoter (Yin. S., et al, Plant Physiol. 115, 437-451, 1997) and the gstAl promoter (Mauch, F. and Dudler. R., Plant Physiol. 102, 1 193-1201. 1993) may be mentioned. A drawback of some of these promoters is that they are also active constitutively or that they do not react to certain types of pathogens. Furthermore, it would be advantageous to have promoters that regulate expression very soon after pathogen infection, i.e. with as short as possible induction times.

Thus, there is still need for promoters that are pathogen-inducible which overcome the disadavantages of the prior art.

Summary of the Invention

We now have found a DNA fragment obtainable from Arabidopsis thaliana, capable of promoting pathogen-inducible transcription of an associated DNA sequence when re-introduced into a plant characterized in that it comprises the nucleotide sequence from 421 to 1424 of SEQ ID NO:6 or its complementary sequence as depicted in SEQ ID NO: 14 or a portion or variant thereof which binds to these sequences under stringent conditions.

Preferably the nucleotide sequence comprises the nucleotide sequence from 222 to 1424 of SEQ LD NO: 6 or its complementary sequence or a portion or variant thereof which binds to these sequences under stringent conditions and more preferably it comprises the nucleotide sequence from I to 1424 depicted in SEQ ID NO: 6, or its complementary sequence or a portion or variant thereof which binds to these sequences under stringent conditions.

Embodiments of the invention are chimeric DNA sequences comprising in the direction of transcription a DNA fragment according to any one of the DNA fragments described above and a DNA sequence to be expressed under the transcriptional control thereof and which is not naturally under transcriptional control of said DNA fragment.

A preferred embodiment is such a chimeric DNA sequence wherein the DNA sequence to be expressed causes the production of an antipathogenic protein, which is preferably selected from the group consisting of chitinases, glucanases, osmotins, maεainins, lectins, saccharide oxidase like hexose oxidases. oxalate oxidase, oxalate decarboxylase. toxins from Bacillus thuringiensis. antifungal proteins isolated from Mirabilis jalapa, Amaranthus, Raphanus, Brassica, Sinapis. Arabidopsis, Dahlia, Cnicus, Lathyrus, Clitoria, Allium seeds. Aralia and Impatiens and albumin-type proteins, such as thionine, napin, barley trypsin inhibitor, cereal gliadin and wheat-alpha-amylase. Another embodiment of the chimeric DNA sequences of the invention is a chimeric

DNA sequence wherein the DNA sequence to be expressed causes the production of a protein that can induce a hypersensitive response, preferably selected from the group consisting of Cf, Bs3 and Prf proteins from tomato, Rpml and Rps2 from Arabidopsis thaliana, N-protein from tobacco, avr proteins from Cladosporium fulvum, harpins from Erwinia and elicitor proteins from (avrBs3, avrRpml, avrRpt2) from Pseudomonas or Xanthomonas.

Further part of the invention are replicons comprising above mentioned chimeric DNA sequences preferably having at least one recognition site for a restriction endonuclease for insertion of a DNA sequence to be expressed under the control of said DNA fragment.

Also included in the invention are microorganism containing such a replicon, plant cells having incorporated into their genome a chimeric DNA sequence according to those described above, and plants essentially consisting of said cells. Such a plant is preferably a dicotyledonous plant. Also part of said plants selected from seeds, flowers, tubers, roots, leaves, fruits, pollen and wood, form part of the invention.

Yet another embodiment of the invention is the use of a DNA fragment as described above for identifying homologues capable of promoting pathogen-induced transcription in a plant. Further use of a chimeric DNA sequence according to the invention for transforming plants and use of a portion or variant of the DNA fragments according to the invention for making hybrid regulatory DNA sequences is part of the invention.

Another object of the invention is the use of a chimeric DNA sequence as described above for conferring pathogen resistance to a plant. Detailed Description of the Figures

The invention is illustrated with reference to the Examples and figures in which :

Figure 1 shows: a photograph of histochemical GUS staining of Arabidopsis thaliana line 533-488 leaf infected with Botrytis cinerea

Figure 2 shows: a Southern blot of genomic DNA of Arabidopsis thaliana line 533- 488 hybridised with GUS probe

Figure 3 shows: a schematic map of plasmid pMOG1040

Figure 4 shows: a schematic map of plasmid pMOG1056 Figure 5 shows: a photograph of GUS stained pMOG1056-transgenic Brassica napus leaf infected with Phoma lingam

Figure 6 shows: a photograph of GUS stained pMOG1056-transgenic Brassica napus stem infected with Phoma lingam

Figure 7-A shows: organisation of the region between open reading frame 3 and 4 on BAC MZB 10 on Arabidopsis chromosome III.

Figure 7-B shows: same region as shown in Figure 1-A but with the insertion of the T-DNA of pMOG553 indicated.

Figure 8 shows: a picture of an agarose gel with in the respective lanes: M = 1 kb

PLUS DNA ladder, Not inoculated = control Arabidopsis leaves not inoculated. Botrytis inoculated = Arabidopsis leaves inoculated with a spore suspension of Botrytis cinerea,

Actin = PCR with actin primers, MZB 10.4 = PCR with MZB 10.4 primers, 22-30 = the number of PCR cycles performed.

Detailed Description of the Invention

The main aspect of the invention are regulatory sequences naturally occurring in

Arabidopsis thaliana. It has been found that upon pathogen infection genes under the regulatory control of the regulatory sequence are highly expressed, indicating pathogen inducibility. Pathogen inducible promoters are of great value in biotechnological resistance engineering. The genomic environment of the regulatory sequence as isolated in Example 4 below, has recently become available (Lin X., et al, EMBL accession number AC009326, August 17. 1999). It has appeared that the sequence as found in Example 4 and cloned before the uidA open reading frame in Example 5 is used in the reversed orientation in situ in front of an open reading frame (designated as MZB 10.4) which codes for a putative serine/threonine protein kinase of about 383 amino acids and of which the nucleotide sequence and the putative amino acid sequence are given in SEQ ID NO: 10 (or SEQ ID NO: 12). It is envisaged that overexpression of this protein or a mutated form thereof will lead to an enhanced pathogen resistance in plants. The protein can effect its antipathogenic function through several actions. First of all it is possible that the protein itself has a function which slows down or hampers the growth of the pathogen or its reproduction, thereby slowing down or stopping the infection. Putative functions here can be interference with the physiology of the pathogen or inhibition of the pathogen's reproductive cycle. A second possible function could be the involvement of the protein in the cascade that leads to a pathogen defense in the plant. A special form of pathogen defence is the hypersensitive response (HR). This is a cascade of events which starts with the recognition of an elicitor molecule coming from the pathogen and through a number of enzymatic reactions in the plant cell causes eventually apoptosis of the cell. Also during this cascade the further defence machinery of the plant will be switched on, whereby the plant produces a broad spectrum of antipathogenic compounds. A third possible function of the protein could be lying in the detoxification of toxins produced by the pathogen. This is the most important for necrotrophic pathogens, which feed on dead tissue. Detoxification then leads to survival of the cells and thus less feeding material for the pathogen.

It has also been established that the inducibility by pathogen infection is unaffected by the orientation of the promoter. In the Experimental section it is shown that expression of the protein kinase which is in nature regulated by the promoter of the invention is induced upon pathogen infection. However, when an ORF coding for the gus-enzyme was inserted with the promoter in the reverse orientation, the promoter of the invention also showed inducibility by pathogen infection. From this it follows that the inducibility is independent of the actual transcription initiation region, but that it is confined in the upstream area (enhancer area) of the promoters. From enhancers it is generally known that they function bidirectional.

In this description the terms 'regulatory sequence' and 'promoter^" are used interchangeably and comprise the total sequence used for driving expression of the ORF which it controls, i.e. including the minimal promoter element and enhancer elements and 5' UTR.

The invention also extends to variants or portions of the promoter having a sequence which hybridizes with the sequence of SEQ ID NO: 12 or SEQ ID NO: 6 under stringent conditions. In this case, stringent conditions are typically reactioins at a temperature between 60°C and 65°C in 0.3 strength citrate buffer saline containing 0.1% SDS followed by rinsing at the same temperature with 0.3 strenght citrate buffer saline containing 0.1% SDS. The present invention provides amongst others chimeric DNA sequences which comprise the DNA fragments according to the invention. The expression chimeric DNA sequence shall mean to comprise any DNA sequence which comprises DNA sequences not naturally found in nature. For instance, chimeric DNA shall mean to comprise DNA comprising the regulatory region which is pathogen-inducible in a non-natural location of the plant genome, notwithstanding the fact that said plant genome normally contains a copy of the said regulatory region in its natural chromosomal location. Similarly, the said regulatory region may be incorporated in the plant genome wherein it is not naturally found, or in a replicon or vector where it is not naturally found, such as a bacterial plasmid or a viral vector. Chimeric DNA shall not be limited to DNA molecules which are replicable in a host, but shall also mean to comprise DNA capable of being ligated into a replicon, for instance by virtue of specific adaptor sequences, physically linked to the regulatory region according to the invention. The regulatory region may or may not be linked to its natural downstream open reading frame.

The open reading frame of the gene which expression is driven by the pathogen- inducible regulatory regions of the invention may be derived from a genomic library. In this latter it may contain one or more introns separating the exons making up the open reading frame that encodes a protein according to the invention. The open reading frame may also be encoded by one uninterrupted exon, or by a cDNA to the mRNA encoding a protein according to the invention. Chimeric DNA sequences according to the invention also comprise those in which one or more introns have been artificially removed or added. Each of these variants is embraced by the present invention.

Enhanced resistance to pathogens can also be engineered by overexpression of the protein which in nature is under control of the promoter of the invention. This protein which is a putative serine/threonine protein kinase preferably is coded by a gene comprising the sequence as depicted in SEQ ID NO: 10. It has been found (by homology searches on sequence databases) that highly homologous sequences can be found in wheat and rice. These sequences also form part of the invention.

It is further envisaged that for exerting its antipathogenic function the protein should be available in an active state. Mutants can be made that are thought to be refractory to inhibitory regulation. Commonly used procedures to identify sequences of interest are known to those skilled in the art. Database searches such as Prosite, containing known modification sites are frequently used. In most protein kinases (e.g. ndrl and Xa21) putative CDPK (Ca2+-dependent protein kinase) and or PKC (protein kinase C) phosphorylation sites can be identified, that could provide a good starting point searching for suitable mutants (Subramanian et al., 1997, Plant Cell 9, 653-664). Mutation of threonine and serine residues to aspartic acid and glutamic acid residues frequently leads to activation, as was shown in many proteins of which the activity is modulated by phosphorylation, e.g. in a MAPK-activated protein (Engel et al., 1995, J. Biol. Chem. 270, 27213-27221), and in a MAP-kinase-kinase protein (Huang et al.,1995 Mol. Biol.Cell 6, 237-245). Also C- and N-terminal as well as internal deletion mutants of these proteins can be tested for suitable mutants.

A more undirected way of identifying interesting mutants of which constitutive activity is induced is through propagation of the protein-encoding DNA in so-called E. coli 'mutator' strains.

Further exemplification of the applicability of mutated proteins for use in generating HR responses to increase pathogen resistance in plants can be found in WO 99/45129, which is here incorporated for reference. In the light of this publication it will be clear that expression of a mutant protein which is active constitutively will cause a hypersensitive response. Therefore, in order to be used in transgenic plants, the mutant protein should be under control of a pathogen inducible promoter. Preferably, this promoter is the promoter which in nature drives expression of the protein, i.e. the promoter of the invention. Alternatively, other pathogen inducible promoters which are or become available in the art and which have inter alia been described in WO 99/45129 can be used.

In order to be capable of being expressed in a host cell a chimeric DNA construct according to the invention will usually be provided with a transcriptional initiation region which may be suitably derived from any gene capable of being expressed in the host cell of choice, as well as a translational initiation region for ribosome recognition and attachment. In eukaryotic cells, an expression cassette usually comprises in addition a transcriptional termination region located downstream of said open reading frame, allowing transcription to terminate and polyadenylation of the primary transcript to occur. In addition, the codon usage may be adapted to accepted codon usage of the host of choice. Further, often a signal sequence may be encoded, which is responsible for the targeting of the gene expression product to subcellular compartments. The principles governing the expression of a chimeric DNA construct in a chosen host cell are commonly understood by those of ordinary skill in the art and the construction of expressible chimeric DNA constructs is now routine for any sort of host cell, be it prokaryotic or eukaryotic.

In order for the chimeric DNA sequence to be maintained in a host cell it will usually be provided in the form of a replicon comprising said chimeric DNA sequence according to the invention linked to DNA which is recognised and replicated by the chosen host cell. Accordingly, the selection of the replicon is determined largely by the host cell of choice. Such principles as govern the selection of suitable replicons for a particular chosen host are well within the realm of the ordinary skilled person in the art.

A special type of replicon is one capable of transferring itself, or a part thereof, to another host cell, such as a plant cell, thereby co-transferring the open reading frame according to the invention to said plant cell. Replicons with such capability are herein referred to as vectors. An example of such vector is a Ti-plasmid vector which, when present in a suitable host, such as Agrobacterium tumefaciens. is capable of transferring part of itself, the so-called T-region. to a plant cell. Different types of Ti-plasmid vectors (vide: EP 0 116 718 Bl) are now routinely being used to transfer chimeric DNA sequences into plant cells, or protoplasts, from which new plants may be generated which stably incorporate said chimeric DNA in their genomes. A particularly preferred form of Ti-plasmid vectors are the so-called binary vectors as claimed in (EP 0 120 516 Bl and US 4,940,838). Other suitable vectors, which may be used to introduce DNA according to the invention into a plant host, may be selected from the viral vectors, e.g. non-integrative plant viral vectors, such as derivable from the double stranded plant viruses (e.g. CaMV) and single stranded viruses, gemini viruses and the like. The use of such vectors may be advantageous, particularly when it is difficult to stably transform the plant host. Such may be the case with woody species, especially trees and vines.

The expression "host cells incorporating a chimeric DNA sequence according to the invention in their genome" shall mean to comprise cells, as well as multicellular organisms comprising such cells, or essentially consisting of such cells, which stably incorporate said chimeric DNA into their genome thereby maintaining the chimeric DNA, and preferably transmitting a copy of such chimeric DNA to progeny cells, be it through mitosis or meiosis. According to a preferred embodiment of the invention plants are provided, which essentially consist of cells which incorporate one or more copies of said chimeric DNA into their genome, and which are capable of transmitting a copy or copies to their progeny, preferably in a Mendelian fashion. By virtue of the transcription and translation of the chimeric DNA according to the invention in some or all of the plant's cells, those cells that comprise said regulatory region will respond to pathogen attack and thus produce the protein encoded by the open reading frame which is under control of the regulatory region. In specific embodiments of the invention this protein will be an antipathogenic protein which is capable of conferring resistance to pathogen infections.

As is well known to those of skill in the art, regulatory regions of plant genes consist of disctinct subregions with interesting properties in terms of gene expression. Examples of subregions as meant here, are enhancers but also silencers of transcription. These elements may work in a general (constitutive) way, or in a tissue-specific manner. Deletions may be made in the regulatory DNA sequences according to the invention, and the subfragments may be tested for expression patterns of the associated DNA. Various subfragments so obtained, or even combinations thereof, may be useful in methods of engineering pathogen resistance, or other applications involving the expression of heterologous DNA in plants. The use of DNA sequences according to the invention to identify functional subregions, and the subsequent use thereof to promote or suppress gene expression in plants is also encompassed by the present invention.

As regards the necessity of a transcriptional terminator region, it is generally believed that such a region enhances the reliability as well as the efficiency of transcription in plant cells. Use thereof is therefore strongly preferred in the context of the present invention.

One of the antipathogenic proteins which may be used in combination with the regulatory region according to the invention is the serine/threonine protein kinase which in nature is under controlled by said region or constitutively active mutants thereof. Further examples of other proteins that may be used include, but are not limited to, β-1,3- glucanases and chitinases which are obtainable from barley (Swegle M. et al., Plant Mol. Biol. 12, 403-412, 1989; Balance G.M. et al, Can. J. Plant Sci. 56, 459-466, 1976 ; Hoj P.B. et al, FEBS Lett. 230, 67-71, 1988; Hoj P.B. et al, Plant Mol. Biol. 13, 31-42, 1989), bean (Boiler T. et al, Planta 157, 22-31. 1983; Broglie K.E. et al, Proc. Natl. Acad. Sci. USA 83, 6820-6824, 1986; Vδgeli U. et al, Planta 174, 364-372, 1988); Mauch F. & Staehelin L.A., Plant Cell 1, 447-457, 1989); cucumber (Metraux J.P. & Boiler T., Physiol. Mol. Plant Pathol. 28, 161-169, 1986); leek (Spanu P. et al, Planta 177, 447-455, 1989); maize (Nasser W. et al, Plant Mol. Biol. 11, 529-538, 1988), oat (Fink W. et al, Plant Physiol. 88, 270-275. 1988), pea (Mauch F. et al, Plant Physiol. 76, 607-611, 1984; Mauch F. et al, Plant Physiol. 87, 325-333, 1988), poplar (Parsons, TJ. et al, Proc. Natl. Acad. Sci. USA 86, 7895-7899, 1989), potato (Gaynor J.J., Nucl. Acids Res. 16, 5210, 1988; Kombrink E. et al, Proc. Natl. Acad. Sci. USA 85. 782-786, 1988; Laflamme D. and Roxby R., Plant Mol. Biol. 13, 249-250, 1989), tobacco (e.g. Legrand M. et al, Proc. Natl. Acad. Sci. USA 84. 6750-6754. 1987; Shinshi H. et al. Proc. Natl. Acad. Sci. USA 84, 89-93, 1987). tomato (Joosten M.H.A. & De Wit P.J.G.M., Plant Physiol. 89, 945-951, 1989), wheat (Molano J. et al. J. Biol. Chem. 254, 4901-4907, 1979), magainins, lectins. toxins isolated from Bacillus thuringiensis. antifungal proteins 00/60086

- 11 -

isolated from Mirabilis jalapa (EP 0 576 483) and Amaranthus (EP 0 593 501 and US 5,514,779), albumin-type proteins (such as thionine, napin, barley trypsin inhibitor, cereal gliadin and wheat-alpha-amylase, EP 0 602 098), proteins isolated from Raplianus, Brassica, Sinapis, Arabidopsis, Dahlia. Cnicus, Lathyrus and Clitoria (EP 0 603 216), oxalate oxidase (EP 0 636 181 and EP 0 673 416), saccharide oxidase (PCT/EP 97/04923). antimicrobial proteins isolated from Allium seeds and proteins from Aralia and Impatiens (WO 95/24485) and the like.

Another use of the inducible promoter is to drive proteins which play a role in the gene-for-gene resistance interaction (e.g. as described in WO 91/15585). Such proteins are, for example, plant proteins such as disclosed in Karrer, E.E. et al. (Plant Mol. Biol. 36, 681-690, 1998). activated ndrl and activated edsl, Cf-proteins, BS3 protein and Pto proteins from tomato, Rpml and Rps2 proteins from Arabidopsis thaliana, the N-gene from tobacco, the avr-elicitor proteins from Cladosporium ftdvum, avrBs3 from Xanthomonas, harpins from Erwinia and the avrPto protein from Pseudomonas. The actual applicability of the invention is not limited to certain plant species, but the plant species to be transformed is preferably from the Cruciferae family. Any plant species that is subject to some form of pathogen attack, may be transformed with chimeric DNA sequences according to the invention, allowing the regulatory region to be induced by pathogen infection thereby triggering production of antipathogenic proteins to be produced in some or all of the plant's cells.

Although some of the embodiments of the invention may not be practicable at present, e.g. because some plant species are as yet recalcitrant to genetic transformation, the practising of the invention in such plant species is merely a matter of time and not a matter of principle, because the amenability to genetic transformation as such is of no relevance to the underlying embodiment of the invention.

Transformation of plant species is now routine for an impressive number of plant species, including both the Dicotyledoneae as well as the Monocotyledoneae. In principle any transformation method may be used to introduce chimeric DNA according to the invention into a suitable ancestor cell, as long as the cells are capable of being regenerated into whole plants. Methods may suitably be selected from the calcium/polyethylene glycol method for protoplasts (Krens, F.A. et al. Nature 296, 72-74, 1982: Negrutiu I. et al„ Plant Mol. Biol. 8, 363-373. 1987), electroporation of protoplasts (Shillito R.D. et al, Bio/Technol. 3, 1099-1102, 1985), microinjection into plant material (Crossway A. et al, Mol. Gen. Genet. 202, 179-185. 1986), DNA (or RNA-coated) particle bombardment of various plant material (Klein T.M. et al, Nature 327, 70, 1987), infection with (non- integrative) viruses and the like. A preferred method according to the invention comprises Agrobacrerium-mediated DNA transfer. Especially preferred is the use of the so-called binary vector technology as disclosed in EP A 120 516 and U.S. Patent 4,940,838.

Tomato transformation is preferably done essentially as described by Van Roekel et al. (Plant Cell Rep. 12. 644-647, 1993). Potato transformation is preferably done essentially as described by Hoekema et al. (Hoekema, A. et al, Bio/Technology 7, 273- 278, 1989).

Generally, after transformation plant cells or cell groupings are selected for the presence of one or more markers which are encoded by plant expressible genes co- transferred with the nucleic acid sequence encoding the protein according to the invention, whereafter the transformed material is regenerated into a whole plant.

Although considered somewhat more recalcitrant towards genetic transformation, monocotyledonous plants are amenable to transformation and fertile transgenic plants can be regenerated from transformed cells or embryos, or other plant material. Presently, preferred methods for transformation of monocots are microprojectile bombardment of embryos, explants or suspension cells, and direct DNA uptake or electroporation (Shimamoto, et al, Nature 338, 274-276, 1989). Transgenic maize plants have been obtained by introducing the Streptomyces hygroscopicus bar-gene, which encodes phosphinothricin acetyltransferase (an enzyme which inactivates the herbicide phosphinothricin). into embryogenic cells of a maize suspension culture by microprojectile bombardment (Gordon-Kamm,, Plant Cell, 2, 603-618, 1990). The introduction of genetic material into aleurone protoplasts of other monocot crops such as wheat and barley has been reported (Lee, Plant Mol. Biol. 13, 21-30, 1989). Wheat plants have been regenerated from embryogenic suspension culture by selecting only the aged compact and nodular embryogenic callus tissues for the establishment of the embryogenic suspension cultures (Vasil, Bio/Technol. 8, 429-434, 1990). The combination with transformation systems for these crops enables the application of the present invention to monocots.

Monocotyledonous plants, including commercially important crops such as rice and corn are also amenable to DNA transfer by Agrobacterium strains (vide WO 94/00977; EP 0 159 418 Bl; Gould J, et al, Plant. Physiol. 95, 426-434, 1991).

Following DNA transfer and regeneration, putatively transformed plants may be evaluated, for instance using Southern analysis, for the presence of the chimeric DNA according to the invention, copy number and/or genomic organization. In addition, or alternatively, expression levels of the newly introduced DNA may be undertaken, using Northern and/or Western analysis, techniques well known to persons having ordinary skill in the art. After the initial analysis, which is optional, transformed plants showing the desired copy number and expression level of the newly introduced chimeric DNA according to the invention may be tested for resistance levels against pathogens..

Alternatively, the selected plants may be subjected to another round of transformation, for instance to introduce further genes, in order to enhance resistance levels, or broaden the resistance.

Other evaluations may include the testing of pathogen resistance under field conditions, checking fertility, yield, and other characteristics. Such testing is now routinely performed by persons having ordinary skill in the art. Following such evaluations, the transformed plants may be grown directly, but usually they may be used as parental lines in the breeding of new varieties or in the creation of hybrids and the like.

To obtain transgenic plants capable of constitutively expressing more than one chimeric gene, a number of alternatives are available including the following: A. The use of DNA, e.g a T-DNA on a binary plasmid, with a number of modified genes physically coupled to a selectable marker gene. The advantage of this method is that the chimeric genes are physically coupled and therefore migrate as a single Mendelian locus.

B. Cross-pollination of transgenic plants each already capable of expressing one or more chimeric genes, preferably coupled to a selectable marker gene, with pollen from a transgenic plant which contains one or more chimeric genes coupled to another selectable marker. Afterwards the seed, which is obtained by this crossing, maybe selected on the basis of the presence of the two selectable markers, or on the basis of the presence of the chimeric genes themselves. The plants obtained from the selected seeds can afterwards be used for further crossing. In principle the chimeric genes are not on a single locus and the genes may therefore segregate as independent loci.

C. The use of a number of a plurality chimeric DNA molecules, e.g. plasmids, each having one or more chimeric genes and a selectable marker. If the frequency of co- transformation is high, then selection on the basis of only one marker is sufficient. In other cases, the selection on the basis of more than one marker is preferred. D. Consecutive transformation of transgenic plants already containing a first, second, (etc), chimeric gene with new chimeric DNA, optionally comprising a selectable marker gene. As in method B, the chimeric genes are in principle not on a single locus and the chimeric genes may therefore segregate as independent loci. E. Combinations of the above mentioned strategies. The actual strategy may depend on several considerations as maybe easily determined such as the purpose of the parental lines (direct growing, use in a breeding programme, use to produce hybrids) but is not critical with respect to the described invention.

In this context it should be emphasised that plants already containing chimeric DNA may form a suitable genetic background for introducing further chimeric DNAs according to the invention, for instance in order to enhance the production antipathogenic substances, thereby enhancing resistance levels. The cloning of other genes corresponding to proteins that can suitably be used in combination with the regulatory DNA fragments, and the obtention of transgenic plants, capable of relatively over-expressing same, as well as the assessment of their effect on pathogen resistance in planta, is now within the scope of the ordinary skilled person in the art.

Plants with improved resistance against pathogens may be grown in the field, in the greenhouse, or at home or elsewhere. Plants or edible parts thereof may be used for animal feed or human consumption, or may be processed for food, feed or other purposes in any form of agriculture or industry. Agriculture shall mean to include horticulture, arboriculture, flower culture, and the like. Industries which may benefit from plant material according to the invention include but are not limited to the pharmaceutical industry, the paper and pulp manufacturing industry, sugar manufacturing industry, feed and food industry, enzyme manufacturers and the like.

The advantages of the plants, or parts thereof, according to the invention are the decreased need for biocide treatment, thus lowering costs of material, labour, and environmental pollution, or prolonging shelf-life of products (e.g. fruit, seed, and the like) of such plants. Plants for the purpose of this invention shall mean multicellular organisms capable of photosynthesis, and subject to some form of pathogen attack. They shall at least include angiosperms as well as gymnosperms, monocotyledonous as well as dicotyledonous plants.

EXAMPLE 1

Construction Arabidopsis pMOG553 promotertagging library

The T-DNA sequence of the promoter tagging construct pMOG553 is available in the EMBL database under accession number X84105. The construct was introduced into Agrobacterium tumefaciens strain MOG101 and used for Arabidopsis thaliana C24 root transformation. More than 1100 transgenic plants were generated, grown and allowed to self- fertilize and the resulting S 1 seeds were harvested.

EXAMPLE 2 Infection of Arabidopsis plants with B. cinerea

Three weeks old Arabidopsis seedlings were transferred to potting soil in 5.5 cm pots and grown for one more week at 18°C. Just before inoculation of the plants leaf samples were taken and a histochemical GUS staining was performed as described in

Goddijn et al. (The Plant Journal (1993) 4(5): 863-873). The plants were sprayed with a Botrytis cinerea spore suspension of 1.2 x 10⁶ spores/ml. After 24 hours and after 48 hours leaves which showed disease symptoms were harvested and again a histochemical

GUS staining was performed.

Line number 488 showed expression of the GUS gene just around the Botrytis infection site (see Figure 1). EXAMPLE 3

Isolation of Botrytis inducible promoter by inverse PCR.

For the isolation of the 5' T-DNA flanking sequence genomic DNA was isolated from leaves of pMOG553 line number 488. The genomic DNA was subjected to restriction enzyme digestion with five different enzymes, EcoR I, EcoR V, Hinc U. Mlu I and Nsp I. For each reaction about 2 μg of DNA was digested in 100 μl water in a lx concentration of the appropriate reaction buffer and 30 units of restriction enzyme for 16 hours at 37°C. The reaction mixtures were extracted with 1 volume phenol/chloroform/isoamylalcohol (25:24:1, v/v) and precipitated with 2.5 volumes 96% ethanol. washed with 70% ethanol and dissolved in 50 μl water. 25 μl of the mixture was separated on a 0.8% agarose gel in lx TBE buffer and transferred to a Hybond-N+ (Amersham Life Sciences) membrane using capillary blotting with 0.4 M NaOH. The blot was hybridized (16 hours, 65°C) using a 560 bp GUS fragment (SEQ ID NO: 1; from the Nco I site on the ATG start codon until the first EcoR V site) labelled with ^j2P-dCTP as a probe. Then the blot was washed with a stringency of 0.2x SSC/1% SDS at 65 °C. The results of the southern blot (see Figure 2 and table 1) indicated that the T-DNA was only present in one single copy.

Table 1: Results southern blot and inverse PCR with calculated promoter sizes for each restriction enzyme used.

Restriction enzyme band size on band size iPCR size promoter southern blot sequence

EcoR I 3.0 kb 1.0 kb 0.5 kb

EcoR V 2.6 kb 2.0 kb 1.8 kb

Hinc II 1.2 kb 0.6 kb 0.4 kb

Mlu l 7.0 kb

Nsp I 0.8 kb 0.2 kb

(- means not amplified)

The remaining 25 μl was used for ligation in 100 μl lx ligation buffer, using 2 units T4 DNA ligase (Gibco BRL) at 14°C for 16 hours. The reaction mixtures were again extracted with phenol/chloroform/isoamylalcohol and the DNA was precipitated with ethanol. The ligated DNA was then linearized with Sn B I, extracted with phenol/chloroform/isoamylalcohol, precipitated with ethanol and dissolved in 25 μl water. 5 μl of this DNA sample was used as a template in a PCR reaction with primer GUSINV5: 5'CTT TCC CAC CAA CGC TGA TC3' (SΕQ ID NO: 2) in all reactions and as a second primer for the EcoR I reaction GUS8 5'CGC ACC ATC GTC GGC TAC AGC3' (SΕQ ID NO: 3) and as a second primer for the other reactions GUS7 5'GTA ATG CTC TAC ACC ACG CCG3' (SΕQ ID NO: 4). 25 pmol of each primer, 0.5 μl of a 20 mM dNTP solution, 0.5 units Taq DNA polymerase (Gibco BRL) were used to amplify the promoter fragment (1 cycle: 5' 95°C, 5' 55°C. 5' 72°C; 25 cycles: 1' 95°C, 1' 55°C, 2' 72°C; 1 cycle: 1' 95°C, 1' 55°C, 10' 72°C). The results of the PCR reactions are listed in table 1.

The 0.6 kb Hinc U fragment was cut out, purified from the agarose gel and cloned into the T-vector (Promega, Madison WI, USA) as described by the manufacturer. Identity of the cloned PCR fragment was confirmed by DNA sequence analysis.

EXAMPLE 4 Isolation of a genomic promoter fragment For the isolation of a large promoter fragment from the Arabidopsis genome a genomic Arabidopsis thaliana C24 wildtype library was screened. For the library construction genomic Arabidopsis C24 DNA was partially digested with SauHIa, size selected and cloned into host vector lambda GEM 11.

The screening of the genomic library was done using a 401 bp Hind HI - Hwc II fragment (SEQ ID NO: 5) from the T-vector clone harbouring the 0.6 kb PCR fragment (described in Example 3) during the complete procedure. The genomic library contained 7.5 x 10⁹ pfu/ml. After a first screening round, 42 positive plaques were obtained. Agar plugs of 20 plaques were collected in 1 ml SM buffer and a drop chloroform. Dilutions (10° and 10^"4 times) were made, combined with E. coli KW251 cells and plated on agar. From 18 of the 20 plates each 2 agar plugs containing single plaques were removed. Dilutions of 10 " and 10^" times of each plug eluate were combined with E. coli KW251 and plated on agar. A plate lysate was prepared from 10 pure plaques. Lambda DNA was isolated from the 10 clones and analysed for their insert by restriction enzyme analysis with EcoR I, EcoR V and Sst I. After separation on a agarose gel the DNA was transferred to a positively charged nylon membrane and hybridized with the 401 bp 488 probe (SΕQ ID NO: 5). Hybridizing bands of ± 4 kb (Sst I - Sst I fragment) of two different subclones were isolated and subcloned into high copy cloning vector pUC18 (Yanisch-Perron, C, Vieira, J. and Messing, J. (1985) Gene 33, 103-119) also digested with Ss l. Clones containing inserts of the correct size (4 kb) were selected and subjected to restriction enzyme analysis, southern blotting and hybridization with the 401 bp 488 probe (SΕQ ID NO: 5). A 2.3 kb hybridizing Sst I - EcoR V fragment was subcloned into high copy cloning vector pBKS⁺ (Stratagene) and digested with Sst I - EcoR V. A clone containing an insert of the correct size was selected and the DNA sequence of the insert was determined (SEQ ID NO: 6). This genomic clone contained the region identical to the original 400 bp 488 PCR fragment, an approximately 500 bp region downstream of the T-DNA insertion and about 1400 bp distal promoter sequence. The T-DNA insertion site was probably located at position 1813 in SEQ ID NO: 6. This DNA sequence was used in BLAST homology searches against the EMBL database and EST database where no relevant homologues could be found.

EXAMPLE 5 Construction prom.oter-gM.s- fusions The 400 bp promoter fragment was fused to the uidA open reading frame keeping the fusion almost identical as in the original plant line 553-488. One modification was made introducing a Nco I restriction site overlapping the ATG startcodon of the UidA open reading frame (ORF). Primers were developed for the amplification of the fragment from the Arabidopsis genome: Primer LS259 (5'CGT ACC ATG GGG GAC TGA CC3', SEQ ID NO: 8) introducing a Nco I restriction site overlapping the ATG startcodon and primer LS260 (5'AGC CGA GCT CGT TGA CAA AAA AAG TAA A AT AAA GTT C3', SEQ ID NO: 9) introducing a Sst I restriction site upstream of the 400 bp promoter fragment. The promoter was amplified using 25 pmol of both primers, 1 μl 20 mM dNTP's and 5 units pfu DNA polymerase for 5 cycles at 1' 95°C, 1' 37°C, 2' 72°C; 30 cycles 1' 95°C, 1' 55°C, 2' 72°C and 1 cycle at 1' 95°C, 1' 55°C, 10' 72°C. The obtained PCR product was purified, digested with Sst I and Nco I and ligated into a Sst I, Nco I digested cloning vector containing GUSintron (Jefferson et α/.,(1987) EMBO J 6: 3901- 3907) followed by the 3' untranslated region of the potato proteinase inhibitor H. gene (Thornburg et al, 1987, Proc. Natl. Acad. Sci. USA 84, 744-748) which contains sequences needed for polyadenylation (An et al, 1989, Plant cell 1, 115-122). The resulting plasmid was named pMOG1039. The complete expression unit was then transferred to binary vector pMOG800 (deposited at the Centraal Bureau voor Schimmelcultures, Baarn, The Netherlands, under CBS 414.93, on august 12, 1993) using restriction enzymes Sst I and EcoR I. The resulting plasmid was designated pMOG1040 (Figure 3). For the construction of the 1800 bp 488 promoter a 1400 bp upstream fragment of the promoter was fused to the 400 bp fragment using the H c II restriction site. Therefore the 400 bp promoter was excised from vector pMOG1039 with BamH I and Hmc II and ligated into a likewise digested cloning vector pBKS⁺ (Stratagene). The resulting vector was then digested with Hmc II and the 1400 bp upstream H c II fragment derived from SEQ ID NO: 6 was ligated into this vector. A clone with the promoter elements fused in a proper way was digested with Xho I and BamH I and ligated into binary vector pMOG1040 digested with Xho I and BamH I resulting in binary vector pMOG1056 (Figure 4). Both binary vectors were transferred by electroporation to Agrobacterium tumefaciens strain EΗA105 for transformation of potato and tomato, strain MOG101 for transformation of tobacco and Arabidopsis thaliana and strain MOG301 for transformation of Brassica napus.

EXAMPLE 6 Transformations of 488 promoter gus constructs to A. thaliana and B. napus Arabidopsis transformation

Described below is the method used for transformation of root segments of Arabidopsis thaliana cv. C24 using Agrobacterium tumefaciens. The binary vectors for this transformation method are identical to those described above. Six mg of Arabidopsis seeds were germinated in a flask containing liquid Germination medium under 16 h light period (1700 lux) at 24°C and a 8 h dark period at 21°C at 80 rpm. (The contents of various media can be found in Table X). Roots of 9 days old seedlings were isolated in a sterile petridish and collected in a drop of Germination Medium (GM). Roots were cut in segments of approximately 3-5 mm and approximately 100 explants were spread evenly on a nylon membrane (O 8 cm) which was placed on plates containing Callus Inducing Medium (CIM).The plates were incubated 3 days under the same conditions as described above.

The Agrobacterium strain used in this study harboured a rifampicin selection marker in a C 58 chromosomal background. The construction of the helper strain

MOG101 is decribed by Hood et al. (1993). Agrobacteria were grown overnight in LB medium with antibiotics (rifampicin 20 mg/1, kanamycin 100 mg/1). The overnight culture was diluted 1:10 in LB without antibiotics and grown for approximately for 3 hours. Bacterial suspensions were centrifuged at 1600xg for 15 minutes at room temperature. Bacteria were resuspended in GM and adjusted to OD600=0.1 and used for cocultivation.

The membrane containing approximately 100 explants was incubated for 2 minutes with the Agrobacterium suspension and dried on sterile filter paper to remove excess of bacteria.The membrane with explants are cultured for 48 h on CIM plates. After rinsing the membrane and explants with liquid GM these were incubated on Shoot Induction Medium (SIM) plates containing several concentrations of cyanamide or kanamycin. After 5 days the membrane with the explants was transferred to the same medium (SIM) for subculture. The second subculture was after 2 weeks. Approximately four weeks after cocultivation 60 shoots per cyanamide concentration were excised and placed on plates with Shoot Elongation Medium (SEM) containing 30 mg/1 cyanamide. Shoots which were able to root are tested on their transgenic character by testing leaflets and flowers for expression of the gus gene using a histochemical GUS assay.

Transformation of Brassica napus wad performed as described in Bade J.B. and Damm, B.: Agrobαcterm -mediated transformation of rapeseed. In: Potrykus, I. and Spangeneberg, G. (eds) Gene Transfer to Plants, Springer verlag, heidelberg, 1995, pp. 30-38.

11

Table A

Media required for Arabidopsis thaliana C24 root transformation

Media Media GM CIM SIM SEM components

Ingredients macro elements B5 B5 B5 MS micro elements B5 B5 B5 MS vitamins B5 B5 B5 B5 sucrose (g/1) 10 glucose (g/1) 20 20 20

Daichin agar (g/1) 10 10 10

Hormones 2,4-D 0.5 kinetin 0.05

2-ip 5

IAA 0.15

Antibiotics vancomycin 100 50 carbenicillin 500 cefotaxime 100

EXAMPLE 7 Expression profiles of promoter-gus fusions in transgenic plants after fungal infection.

Transgenic Arabidopsis plants harbouring the 400 bp promoter gus construct

(pMOG1040) and the 1800 bp promoter gus construct (pMOG1056) were infected with

Botrytis cinerea as described in Example 1. From the pMOG1040 construct 33 plants were tested after infection with B. cinerea. None of the transgenic lines with the 400 bp promoter element showed any inducible GUS expression around the fungal infection sites. 14 out of 47 Arabidopsis plants harbouring the 1800 bp promoter element

(pMOG1056) in front of gus show inducible gus expression after infection with B. cinerea. Brassica napus glasshouse plants were infected on detached leaves. Leaves were detached and placed in wet floricultural foam. Small incisions were made and small droplets of a B. cinerea spore suspension were applied on the incision area allowing the fungus to enter the plant more easily. Fungal infections were allowed to proceed at 18°C and at a high relative humidity (± 90%).

Table 2: Fungal inducible GUS expression monitored in transgenic Brassica napus plants harbouring the pMOG1056 construct after infection with Botrytis cinerea (detached leaves).

Plant line number Expression after background expression B. cinerea infection

1056-1 +

1056-4 nt nt

1056-5 nt nt

1056-6 +

1056-7

1056-8

1056-9 +

1056-10

1056-11

1056-12

1056-13 +

1056-14

1056-15 +

1056-16 nt nt

1056-17

1056-18

1056-19 nt nt

1056-20 +

1056-22 nt nt

1056-23

1056-24 nt nt note: + = GUS expression, - = no detectable GUS expression, nt = not tested. In several of the lines background expression was noted. Since no background was detected in whole plants (Fig. 3) this phenomenon could be explained by the fact that the promoter is also wound-inducible.

Similar infection assays were performed on in vitro plantlets grown in small glass tubes. Plants were inoculated with a spore suspension of the Brassica napus pathogen Phoma lingam. Small droplets of the spore suspensions were applied directly on the leaves and the disease was allowed to develop for 6 days. When small lesion were visible, leaves were removed from the plant and tested for expression of the GUS gene. About 50% of the transgenic lines show inducible expression of the GUS gene just around the sites of fungal infection (an example is shown in Figure 5). The Phoma lingam infection was left to proceed until stem lesions were developing (at approx. 2 weeks after inoculation). Stem segments containing lesions were removed and stained. In several lines expression around the stem lesions was visible (an example is shown in Figure 6).

Example 8

Analysis of the DNA sequence of the complete 488 promoter

The complete sequence of the 2.3 kb genomic clone was used in a BLAST homology search against the EMBL database. An almost exact hit was found in the sequences of BAC MZB10 (Lin et al, EMBL AC009326) and BAC T16011 (Lin et al, EMBL AC010871). Both BAC's have an overlap of 17450 bp at the SP6 site of the BAC's and are located near molecular marker CIC7A12R (YAC CIC7A12) on Arabidopsis chromosome III.

The T-DNA of the pMOG553 promotertagging construct in Arabidopsis line 553-

488 is inserted between the third and the fourth open reading frame on BAC MZB 10. The location of the insertion site is 398 bp downstream of the third ORF (MZB 10.3), a protein of unknown function and 1591 bp upstream of the translation start of the putative receptor serine threonine protein kinase. the fourth ORF (MZB 10.4). The T-DNA is inserted in such an orientation that the T-DNA right border is situated at the MZB 10.4 site and the left border at the MZB 10.3 site (Figure 7A). Table 3: Fungal inducible GUS expression monitored in transgenic Brassica napus plants harbouring the pMOG1056 construct after infection with Phoma lingam (in vitro)

Plant line number P. lingam infection background Stem lesions

1056-4 + - +

1056-5 +

1056-6 + - +

1056-7

1056-8

1056-9 + - + 1056-10

1056-11 nt nt nt

1056-12 + - +

1056-13 + - +

1056-14 +

1056-15 + - +

1056-16 - - nt

1056-17 - - nt

1056-18 - - nt

1056-19 - - nt

1056-20 + - nt

1056-22 - - nt 1056-23 1056-24

note: + = GUS expression. - = no detectable GUS expression, nt = not tested. The T-DNA of pMOG553 is located at an identical place in the sequence of BAC T16011. When the DNA sequence of both regions in BAC MZB10 and BAC T16011 were compared they appeared to be identical over the entire region of the putative receptor serine threonine kinase (MZB10.4/T16011.3). Computer based prediction of the open reading frames and the subsequent translation into amino acid sequences revealed a difference between both accessions (MZB10.4, Lin et al., AC009326 and T16011.3. Lin et al., AC010871). The difference was found in the prediction of the splicing site between intron five and exon six. resulting in two different protein sequences. The amino acid sequence of the MZB 10.4 putative receptor serine threonine protein kinase (SEQ ID NO: 11) is 383 Aa in size and contains a protein kinase ATP binding region (Aa 42 to 64 in SEQ ID NO: 11), a protein kinase active site (Aa 158 to 170 of SEQ ID NO: 11), a Leucine zipper motif (Aa 249 to 270 in SEQ ID NO: 11) and a region with similarity to motifs found in Alpha Isopropylmalate/homocitrate synthase enzymes(Aa 54 to 64 in SEQ ID NO: 11).

The amino acid sequence of the T16011.3 putative protein kinase is 384 Aa in size and contains a protein kinase ATP binding region (Aa 42 to 64 in SEQ ID NO: 13), a protein kinase active site (Aa 158 to 170 of SEQ ID NO: 13) and a region with similarity to motifs found in Alpha Isopropylmalate/homocitrate synthase enzymes(Aa 54 to 64 in SEQ ID NO: 13). The T16011.3 putative protein kinase differs from MZB 10.4 between Aa position 254 and 259 (SEQ ID NO: 11) which causes a disruption of the leucine zipper motif which is predicted (based on similarity) in MZB10.4 and not in T16011.3. Leucine zippers are known to be involved in homo- or heterodimerization of proteins, often transcription factors.

The regulatory region between the T-DNA insertion and the start of the MZB 10.4 coding region is responsible for the pathogen induced expression as observed in promotertagging line 553-488 and in transgenic Arabidopsis or Brassica napus plants transformed with the pMOG1056 construct. The truncated promoter fragment that was used in pMOG1040 and described in Example 6 did not confer fungal induced expression in transgenic Arabidopsis plants. From these experiments we conclude that elements necessary for pathogen induced expression of the 488 promoter are located upstream of the 400 bp promoter element (relative to the T- DNA insertion) and the minimal promoter (TATA box, trancription start and 5' untranslated region) of the MZB 10.4 putative serine threonine receptor kinase. Computer algorithms predict that the minimal promoter spans about 200 basepairs (the complementary strand between nucleotides 421-223 of SEQ ID NO: 6). The sequence of the region containing the elements necessary for pathogen induced expression is given in SEQ ID NO: 14.

Example 9

MZB 10.4 RT-PCR on Arabidopsis

A primer set was designed on the second and third exon of the MZB 10.4 gene spanning the second intron. Primers FR-MZB 10.4-562 (5'GAT TTG CAC CAA CAA TGT GAG G3' SEQ ID NO: 15) and FR-MZB 10.4-563 (5'GGT ACT CAT AGA CAA GAA TCC G3' SEQ ID NO: 16) were used in a PCR on genomic DNA from Arabidopsis thaliana c.v. C24. A PCR fragment of 381 bp was amplified and cloned into the pGEM- T vector (Promega). Wildtype seeds were germinated on MSB5 medium. Seedlings were transferred to pots and grown for three weeks at 20°C and a relative humidity of 80%. The plantlets were inoculated by spraying a B. cinerea spore suspension in 0.8% KH₂PO₄ and 0.2% sucrose of ± 1.0 x 10⁶ spores/ml. After three days when symptoms started to develop samples were taken and frozen in liquid nitrogen and stored at -80°C. Poly A⁺ RNA was extracted using the Quickprep Micro mRNA purification kit

(Amersham Pharmacia Biotech, Uppsala, Sweden). cDNA was prepared using equal amounts of mRNA using the Ready-To-Go T-Primed First-Strand kit (Amersham Pharmacia Biotech, Uppsala, Sweden). 5 μl or 2 μl of first strand cDNA was used in PCR reactions using 25 pmol of each of the primers FR-MZB 10.4-562 and FR-MZB 10.4-563, 0.5 μl 20 mM dNTP's (Gibco BRL). 2.5 units Platinum Taq DNA polymerase (Gibco BRL)and were subjected to 22. 24, 26, 28 or 30 cycles of 30" at 92°C, 30" at 55°C and 30" at 72°C. Equal volumes were analysed on a 2.0% agarose gel and stained with ethidium bromide. As a control a primer set was developed on homologues regions in the Arabidopsis thaliana actin genes. Primers FR-Actin-586 (5'GAT GAT ATG GAG AAG ATT TGG CAT C3\ SEQ ID NO: 17) and FR-Actin-587 (5'CAC AAT ACC GGT TGT ACG ACC AC3'. SEQ ID NO: 18) were used in control PCR's on the same cDNA samples under identical conditions. A picture of the RT-PCR results is shown in Figure 8.

Example 10 Isolation and cloning of the MZB 10.4 promoter

Primers were designed for the isolation of the MZB 10.4 promoter from the Arabidopsis genome by PCR. Primer FR-MZB 10.4-559 (5'GCG AGC TCT GTA CGA TAA GAA TCTCCA G3', SEQ ID NO: 19) and primer FR-MZB 10.4-560 (5'GCC CAT GGC TAG AAG TCC GAA GC3' SEQ ID NO: 20) and used in a PCR on genomic DNA from Arabidopsis thaliana cv C24. A 1.6 kb fragment was amplified and is cloned into pMOG1052 digested with Sac I and Nco I fused to the GUSintron reporter gene (Jefferson et α/.,(1987) EMBO J 6: 3901-3907) followed by the 3' untranslated region of the potato proteinase inhibitor II gene (Thornburg et al., 1987, Proc. Natl. Acad. Sci. USA 84, 744- 748) which contains sequences needed for polyadenylation (An et al, 1989, Plant cell 1, 115-

122) resulting in pMOG1600. The entire chimeric gene flanked by restriction sites Sac I and

Kpn I is then transferred to pMOG800 (deposited at the Centraal Bureau voor Schimmelcultures, Baarn, The Netherlands, under CBS 414.93, on august 12, 1993) digested with Sac I and Kpn I, resulting in pMOG1601. Plants are transformed with constructs using essentially the same method as described in Example 6. Expression profiles are then made essentially according to the same methods as described in Example 7.

Claims

1. A DNA fragment obtainable from Arabidopsis thaliana, capable of promoting pathogen-inducible transcription of an associated DNA sequence when re-introduced into a plant characterized in that it comprises the nucleotide sequence from 421 to 1424 of SEQ ID NO: 6 or its complementary sequence as depicted in SEQ ID NO: 14 or a portion or variant thereof which hybridizes to these sequences under stringent conditions.

2. A DNA fragment according to claim 1, characterized in that it comprises the nucleotide sequence from 222 to 1424 of SEQ ID NO: 6 or its complementary sequence or a portion or variant thereof which hybridizes to these sequences under stringent conditions.

3. A DNA fragment according to claiml, characterized in that it comprises the nucleotide sequence from 1 to 1424 depicted in SEQ ID NO: 6 or its complementary sequence or a portion or variant thereof which hybridizes to these sequences under stringent conditions.

4. A chimeric DNA sequence comprising in the direction of transcription a DNA fragment according to any one of claims 1 to 3 and a DNA sequence to be expressed under the transcriptional control thereof and which is not naturally under transcriptional control of said DNA fragment.

5. A chimeric DNA sequence according to claim 4, wherein the DNA sequence to be expressed causes the production of an antipathogenic protein.

6. A chimeric DNA sequence according to claim 5, wherein said antipathogenic protein is selected from the group consisting of chitinases, glucanases, osmotins, magainins, lectins, saccharide oxidase, oxalate oxidase, oxalate decarboxylase, toxins from Bacillus thuήngiensis, antifungal proteins isolated from Mirabilis jalapa, Amaranthus, Raphanus, Brassica, Sinapis, Arabidopsis, Dahlia, Cnicus, Lathyrus, Clitoria, Allium seeds, Aralia and Impatiens and albumin-type proteins, such as thionine, napin, barley trypsin inhibitor, cereal gliadin and wheat-alpha-amylase.

7. A chimeric DNA sequence according to claim 4, wherein the DNA sequence to be expressed causes the production of a protein that can induce a hypersensitive response, preferably selected from the group consisting of Cf, Bs3 and Pto proteins from tomato, Rpml and Rps2 from Arabidopsis thaliana, N-protein from tobacco, avr proteins from Cladosporium fidvum, harpins from Erwinia and elicitor proteins (avrBs3, avrRpml, avrRpt2) from Pseudomonas or Xanthomonas.

8. A replicon comprising a chimeric DNA sequence according to any one of claims 4 to 7.

9. A replicon comprising in the direction of transcription a DNA fragment according to any one of claims 1 to 3 and at least one recognition site for a restriction endonuclease for insertion of a DNA sequence to be expressed under the control of said DNA fragment.

10. A microorganism containing a replicon according to any one of claims 8 or 9.

11. A plant cell having incorporated into its genome a chimeric DNA sequence according to any one of claims 4 to 7.

12. A plant essentially consisting of cells according to claim 11.

13. A plant according to claim 12 which is a dicotyledonous plant.

14. A plant according to any one of claims 11 to 13 belonging to the Cruciferae family.

15. A part of a plant selected from seeds, flowers, tubers, roots, leaves, fruits, pollen and wood, obtained from a plant according to any one of claims 12 to

14.

16. Use of a DNA fragment according to any one of claims 1 to 3 for identifying homologues capable of promoting pathogen-induced transcription in a plant.

17. Use of a chimeric DNA sequence according to any one of claims 4 to 7 for transforming plants.

18. Use of a portion or variant according to any of claims 1- 3 for making hybrid regulatory DNA sequences.

19. Use of a chimeric DNA sequence according to any of claims 4 to 7 for conferring pathogen resistance to a plant.